美國
US 12,702,667 B2
Focal adhesion kinase inhibitor as a therapeutic agent in diabetes
US 12,702,667 B2 是美國專利商標局（USPTO）的核准專利，日期 2026-08-11。申請人：University of Pittsburgh - Of the Commonwealth System of Higher Education。PDF 可在本頁下載，未登入每天最多 5 篇。
有人下載過這份 PDF 後，這裡會顯示首頁預覽。
- 申請人
- University of Pittsburgh - Of the Commonwealth System of Higher Education
- 發明人
- Farzad Esni; Jing Hu
- 公開日
- 2026-08-11
- 申請日
- 2019-08-13
- 文件種類
- B2 核准公告
- 也寫作
- US 12,702,667 B2 · US12702667 · 12702667
摘要
It is disclosed herein that a FAK inhibitor induces conversion of acinar cells into beta cells. Methods are provided for increasing beta cell proliferation by administering an effective amount of a FAK inhibitor to a subject in need thereof. Methods are also provided for treating a subject with diabetes or at risk of developing diabetes, comprising administering to the subject a therapeutically effective amount of a FAK inhibitor.
這裡只列摘要開頭，完整內容在 PDF 裡。
不用登入，每天可下載 5 篇（今天還剩 5 篇）。批次下載與 OA 引證整理需免費註冊。
專利局網站： 美國專利商標局（USPTO）